Alert warns about cybersecurity risk with insulin pump system
A potential issue with the Medtronic MiniMed 600 Series Insulin Pump System's communication protocol could allow unauthorized access to the device, the FDA said.
The FDA issued an alert about a potential cybersecurity risk with the Medtronic MiniMed 600 Series Insulin Pump System on Sept. 20.
A potential issue with the communication protocol could allow unauthorized access to the pump system while the pump is being paired with other system components. Unauthorized access could potentially cause the pump to deliver too much or too little insulin, the FDA said.
The agency is working with the company to identify, communicate, and prevent adverse events associated with this issue and said it will keep the public informed if significant new information becomes available.